2 000 new building blocks are synthesized monthly. Here is an important update to our MedChem Highlights from February 2025
Recent News
-
09 April 2025 Press Release
Recursion and Enamine Release New AI-Enabled Targeted Compound Libraries
Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced the generation of screening libraries leveraging tools within its AI/ML platform, the Recursion OS, with Enamine's REAL Space, the world’s largest source of make-on-demand small molecules. Together, the two companies have curated 10 enriched screening libraries from over 15,000 newly synthesized compounds designed to accelerate drug discovery against the hundred most difficult to address biological areas and clinically relevant key drug targets.
-
02 April 2025 Press Release
Enamine and ChemPass Collaborate to Accelerate Hit Discovery
Enamine, the leading provider of chemical compounds and drug discovery services, and ChemPass, a contract research organization for computational and AI-assisted software, today announced their start of strategic partnership to provide hit discovery solutions to their customers.
-
06 March 2025 News
Enamine REAL Compounds: A Practical Overview
Event Timing: Thursday, 24 April, 2025. Event Address: Suwon Convention Center, room 301+302.
Upcoming events
-
Apr 23-25,
2025Delegates
135th General Meeting of the Korean Chemical Society
FOLLOW US
Request product information
Please leave your request for any product you wish. We will be happy to search it for you in our databases or offer its custom synthesis